Overview

Postoperative Chemotherapy and Chemo-radiotherapy for Resected Gastric Cancer

Status:
Completed
Trial end date:
2009-09-01
Target enrollment:
Participant gender:
Summary
This study will determine the feasibility of adjuvant chemotherapy and chemo-radiotherapy for patients with surgically resected adenocarcinoma of the stomach and gastro-esophageal junction.
Phase:
Phase 2
Details
Lead Sponsor:
Hellenic Oncology Research Group
Collaborator:
University Hospital of Crete
Treatments:
Capecitabine
Cisplatin
Docetaxel